SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-049221
Filing Date
2022-09-08
Accepted
2022-09-08 17:58:12
Documents
1
Period of Report
2022-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3536
  Complete submission text file 0001209191-22-049221.txt   5039
Mailing Address C/O FANTEX, INC. 330 TOWNSEND ST., SUITE 234 SAN FRANCISCO CA 94107
Business Address
Monohon Ted (Reporting) CIK: 0001606905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38890 | Film No.: 221234651

Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Issuer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)